Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04798781
Title Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Andrew Hendifar, MD
Indications

gastroesophageal adenocarcinoma

hepatocellular carcinoma

gastric adenocarcinoma

Therapies

Pembrolizumab + Telatinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.